Effect of IL-22 on DNA vaccine encoding LACK gene of Leishmania major in BALB/c mice
Authors:
- Hajar Ziaee HezarjaribiHHHajar Ziaee Hezarjaribi
- Fatemeh GhaffarifarFGFatemeh Ghaffarifar
- Abdolhosein DalimiADAbdolhosein Dalimi
- Zohreh SharifiZSZohreh Sharifi
- Ogholniaz JorjaniOJOgholniaz Jorjani
- 1 July 2013
- journal article
- research article
- Published by Elsevier in Experimental Parasitology
- Vol. 134 (3) , 341-348
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The development and clinical evaluation of second-generation leishmaniasis vaccinesVaccine, 2012
- IL-22 Produced by Human NK Cells Inhibits Growth of Mycobacterium tuberculosis by Enhancing Phagolysosomal FusionThe Journal of Immunology, 2009
- An unexpected discovery of two interferon gamma-like genes along with interleukin (IL)-22 and -26 from teleost: IL-22 and -26 genes have been described for the first time outside mammalsMolecular Immunology, 2006
- A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. majorVaccine, 2004
- DNA vaccines: a reviewJournal of Internal Medicine, 2003
- Thl‐Like Human T‐Cell Clones Recognizing Leishmania gp63 Inhibit Leishmania major in Human MacrophagesScandinavian Journal of Immunology, 1994
- The Adjuvant Effect of Interleukin-12 in a Vaccine Against Leishmania majorScience, 1994
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990
- Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam)Journal of the American Academy of Dermatology, 1986
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976